{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:56:21Z","timestamp":1784051781312,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"General Science and Technology Project of Jiangxi Provincial Health Commission","award":["202210008"],"award-info":[{"award-number":["202210008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05491-w","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T11:54:54Z","timestamp":1755518094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Postpartum colonic squamous cell carcinoma with a BRAFV600E mutation: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Qin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Gen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Rong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Zhang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"11","key":"5491_CR1","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.3390\/Curroncol30110684","volume":"30","author":"G Arup","year":"2023","unstructured":"Arup G, Shravan N. Cancer and pregnancy in the post-Roe v. Wade era: a comprehensive review. Curr Oncol. 2023;30(11):9448\u201357. https:\/\/doi.org\/10.3390\/Curroncol30110684.","journal-title":"Curr Oncol"},{"key":"5491_CR2","volume-title":"Histologic typing of intestinal tumours: WHO technical report 15","author":"BC Morson","year":"1976","unstructured":"Morson BC, Sobin LH. Histologic typing of intestinal tumours: WHO technical report 15. Geneva: World Health Organization; 1976."},{"issue":"3","key":"5491_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/Path.1711290306","volume":"129","author":"GT Williams","year":"1979","unstructured":"Williams GT, Blackshaw AJ, Morson BC. Squamous carcinoma of the colorectum and its genesis. J Pathol. 1979;129(3):139\u201347. https:\/\/doi.org\/10.1002\/Path.1711290306.","journal-title":"J Pathol"},{"issue":"10","key":"5491_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/BF01317044","volume":"28","author":"L Gould","year":"1983","unstructured":"Gould L, Shah JM, Khedekar RR, Burns WA. Squamous cell carcinoma of the splenic flexure of the colon. Dig Dis Sci. 1983;28(10):918\u201322. https:\/\/doi.org\/10.1007\/BF01317044.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"5491_CR5","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1308\/Rcsann.2020.0149","volume":"102","author":"D Linardoutsos","year":"2020","unstructured":"Linardoutsos D, Frountzas M, Feakins RM, Patel NH, Simanskaite V, Patel H. Primary colonic squamous cell carcinoma: a case report and review of the literature. Ann R Coll Surg Engl. 2020;102(9):E1\u20137. https:\/\/doi.org\/10.1308\/Rcsann.2020.0149.","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"5491_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/08941939.2020.1824044","volume":"35","author":"D Schizas","year":"2022","unstructured":"Schizas D, Katsaros I, Mastoraki A, Karela NR, Zampetaki D, Lazaridis II, Tsapralis D, Theodoropoulos GE. Primary squamous cell carcinoma of colon and rectum: a systematic review of the literature. J Invest Surg. 2022;35(1):151\u20136. https:\/\/doi.org\/10.1080\/08941939.2020.1824044.","journal-title":"J Invest Surg"},{"issue":"6","key":"5491_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/BF02560233","volume":"28","author":"DH Palvio","year":"1985","unstructured":"Palvio DH, S\u00f8rensen FB, Kl\u00f8ve-Mogensen M. Stem cell carcinoma of the colon and rectum. Report of two cases and review of the literature. Dis Colon Rectum. 1985;28(6):440\u20135. https:\/\/doi.org\/10.1007\/BF02560233.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"5491_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0022-5347(05)64092-X","volume":"169","author":"G Yurdakul","year":"2003","unstructured":"Yurdakul G, de Reijke TM, Blank LE, Rauws EA. Rectal squamous cell carcinoma 11 years after brachytherapy for carcinoma of the prostate. J Urol. 2003;169(1):280. https:\/\/doi.org\/10.1016\/S0022-5347(05)64092-X.","journal-title":"J Urol"},{"issue":"3","key":"5491_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF02552552","volume":"31","author":"F Michelassi","year":"1988","unstructured":"Michelassi F, Mishlove LA, Stipa F, Block GE. Squamous-cell carcinoma of the colon. Experience at the University of Chicago, review of the literature, report of two cases. Dis Colon Rectum. 1988;31(3):228\u201335. https:\/\/doi.org\/10.1007\/BF02552552.","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"5491_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/S00535-022-01937-w","volume":"58","author":"C Astaras","year":"2023","unstructured":"Astaras C, De Vito C, Chaskar P, Bornand A, Khanfir K, Sciarra A, Letovanec I, Corro C, Dietrich PY, Tsantoulis P, Koessler T. The first comprehensive genomic characterization of rectal squamous cell carcinoma. J Gastroenterol. 2023;58(2):125\u201334. https:\/\/doi.org\/10.1007\/S00535-022-01937-w.","journal-title":"J Gastroenterol"},{"issue":"14","key":"5491_CR11","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.3748\/Wjg.V20.I14.4106","volume":"20","author":"JF Wang","year":"2014","unstructured":"Wang JF, Wang ZX, Xu XX, Wang C, Liu JZ. Primary rectal squamous cell carcinoma treated with surgery and radiotherapy. World J Gastroenterol. 2014;20(14):4106\u20139. https:\/\/doi.org\/10.3748\/Wjg.V20.I14.4106.","journal-title":"World J Gastroenterol"},{"key":"5491_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.12688\/F1000research.24033.1","volume":"9","author":"NA Parker","year":"2020","unstructured":"Parker NA, Hussein Agha Y, Buess CS, Lalich D, Deutsch JM. Case report: management of rectal squamous cell carcinoma - a treatment dilemma. F1000Res. 2020;9:503. https:\/\/doi.org\/10.12688\/F1000research.24033.1.","journal-title":"F1000Res"},{"issue":"1","key":"5491_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF02235191","volume":"42","author":"JV Juturi","year":"1999","unstructured":"Juturi JV, Francis B, Koontz PW, Wilkes JD. Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature. Dis Colon Rectum. 1999;42(1):102\u20139. https:\/\/doi.org\/10.1007\/BF02235191.","journal-title":"Dis Colon Rectum"},{"key":"5491_CR14","doi-asserted-by":"publisher","first-page":"1051786","DOI":"10.3389\/Fonc.2023.1051786","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Du J, Zhang P, Meng W, Xiao H. Squamous cell carcinoma of ascending colon with pMMR\/MSS showed a partial response to PD-1 blockade combined with chemotherapy: a case report. Front Oncol. 2023;13:1051786. https:\/\/doi.org\/10.3389\/Fonc.2023.1051786.","journal-title":"Front Oncol"},{"issue":"8","key":"5491_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.Annonc.2021.03.206","volume":"32","author":"A Grothey","year":"2021","unstructured":"Grothey A, Fakih M, Tabernero J. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines. Ann Oncol. 2021;32(8):959\u201367. https:\/\/doi.org\/10.1016\/j.Annonc.2021.03.206.","journal-title":"Ann Oncol"},{"key":"5491_CR16","doi-asserted-by":"publisher","first-page":"102541","DOI":"10.1016\/j.Ctrv.2023.102541","volume":"115","author":"E Martinelli","year":"2023","unstructured":"Martinelli E, Arnold D, Cervantes A, Stintzing S, Van Cutsem E, Tabernero J, Taieb J, Wasan H, Ciardiello F. European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal Cancer. Cancer Treat Rev. 2023;115:102541. https:\/\/doi.org\/10.1016\/j.Ctrv.2023.102541.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5491_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/1078-0432.CCR-16-0140","volume":"23","author":"D Barras","year":"2017","unstructured":"Barras D, Missiaglia E, Wirapati P, Sieber OM, Jorissen RN, Love C, Molloy PL, Jones IT, McLaughlin S, Gibbs P, Guinney J, Simon IM, Roth AD, Bosman FT, Tejpar S, Delorenzi M. BRAF V600E mutant colorectal cancer subtypes based on gene expression. Clin Cancer Res. 2017;23(1):104\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0140.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5491_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.19.02107","volume":"38","author":"DT Le","year":"2020","unstructured":"Le DT, Kim TW, Van Cutsem E, Geva R, J\u00e4ger D, Hara H, Burge M, O\u2019Neil B, Kavan P, Yoshino T, Guimbaud R, Taniguchi H, Elez E, Al-Batran SE, Boland PM, Crocenzi T, Atreya CE, Cui Y, Dai T, Marinello P, Diaz LA Jr, Andr\u00e9 T. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol. 2020;38(1):11\u20139. https:\/\/doi.org\/10.1200\/JCO.19.02107.","journal-title":"J Clin Oncol"},{"key":"5491_CR19","doi-asserted-by":"publisher","unstructured":"Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg MV, Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, Andr\u00e9 T. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017 Sep;18(9):1182-1191. https:\/\/doi.org\/10.1016\/S1470-2045(17)30422-9. Epub 2017 Jul 19. Erratum in: Lancet Oncol. 2017 Sep;18(9):E510. PMID: 28734759; PMCID: PMC6207072.","DOI":"10.1016\/S1470-2045(17)30422-9"},{"issue":"8","key":"5491_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, Van Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA, Ledeine JM, Cao ZA, Kamble S, Kopetz S, Andr\u00e9 T. Durable clinical benefit with Nivolumab plus Ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.76.9901.","journal-title":"J Clin Oncol"},{"issue":"23","key":"5491_CR21","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de La Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr, KEYNOTE-177 Investigators. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318. https:\/\/doi.org\/10.1056\/NEJMoa2017699.","journal-title":"N Engl J Med"},{"issue":"31","key":"5491_CR22","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.2217\/Fon-2021-0552","volume":"17","author":"R Park","year":"2021","unstructured":"Park R, Lopes L, Lee S, Riano I, Saeed A. The prognostic and predictive impact of BRAF mutations in deficient mismatch repair\/microsatellite instability-high colorectal cancer: systematic review\/meta-analysis. Future Oncol. 2021;17(31):4221\u201331. https:\/\/doi.org\/10.2217\/Fon-2021-0552.","journal-title":"Future Oncol"},{"key":"5491_CR23","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3332\/Ecancer.2022.1489","volume":"16","author":"RM Guerrero","year":"2022","unstructured":"Guerrero RM, Labajos VA, Ballena SL, Macha CA, Lezama MS, Roman CP, Beltran PM, Torrejon AF. Targeting BRAF V600E in metastatic colorectal cancer: where are we today? Ecancermedicalscience. 2022;16:1489. https:\/\/doi.org\/10.3332\/Ecancer.2022.1489.","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"5491_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1200\/JCO.21.01015","volume":"40","author":"HJ Lenz","year":"2022","unstructured":"Lenz HJ, Van Cutsem E, Luisa Limon M, Wong KYM, Hendlisz A, Aglietta M, Garc\u00eda-Alfonso P, Neyns B, Luppi G, Cardin DB, Dragovich T, Shah U, Abdullaev S, Gricar J, Ledeine JM, Overman MJ, Lonardi S. First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. J Clin Oncol. 2022;40(2):161\u201370. https:\/\/doi.org\/10.1200\/JCO.21.01015.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5491_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/S41591-022-02181-8","volume":"29","author":"J Tian","year":"2023","unstructured":"Tian J, Chen JH, Chao SX, Pelka K, Giannakis M, Hess J, Burke K, Jorgji V, Sindurakar P, Braverman J, Mehta A, Oka T, Huang M, Lieb D, Spurrell M, Allen JN, Abrams TA, Clark JW, Enzinger AC, Enzinger PC, Klempner SJ, McCleary NJ, Meyerhardt JA, Ryan DP, Yurgelun MB, Kanter K, Van Seventer EE, Baiev I, Chi G, Jarnagin J, Bradford WB, Wong E, Michel AG, Fetter IJ, Siravegna G, Gemma AJ, Sharpe A, Demehri S, Leary R, Campbell CD, Yilmaz O, Getz GA, Parikh AR, Hacohen N, Corcoran RB. Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial. Nat Med. 2023;29(2):458\u201366. https:\/\/doi.org\/10.1038\/S41591-022-02181-8.","journal-title":"Nat Med"},{"key":"5491_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.2022.40.4_suppl.012","volume":"40","author":"VK Morris","year":"2022","unstructured":"Morris VK, Parseghian CM, Escano M, et\u00a0al. Phase I\/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, BRAF V600E metastatic colorectal cancer. J Clin Oncol. 2022;40:12\u201312.","journal-title":"J Clin Oncol"},{"key":"5491_CR27","doi-asserted-by":"publisher","first-page":"309439","DOI":"10.1155\/2013\/309439","volume":"2013","author":"JL Agnew","year":"2013","unstructured":"Agnew JL, Abbadessa B, Leitman IM. Strategies to evaluate synchronous carcinomas of the colon and rectum in patients that present for emergent surgery. Int J Surg Oncol. 2013;2013:309439. https:\/\/doi.org\/10.1155\/2013\/309439.","journal-title":"Int J Surg Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05491-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05491-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05491-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:48:10Z","timestamp":1757468890000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05491-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5491"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05491-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out according to the Declaration of Helsinki and approved by Jiangxi Provincial People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}